CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cadrenal Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.06−0.03 (-2.75%)
Close on Oct 19, 2026
- Market cap
- $3.09M
- P/E (TTM)
- –
- Dividend yield
- 1556.60%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3.2%
0M of 4M shares
Institutional holders
17
6 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 27 sales
Net sold $542.12K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Quang X. Pham | 421,042 | 23.60% | 13D (active) | Jan 23, 2025 |
| The PNC Financial Services Group, Inc. | 233,219 | 8.13% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CVKD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 50,137 | 1.41% | $167.46K | +4,936 | 0.00% |
| Hrt Financial LP | 29,055 | 0.81% | $97 | New | 0.00% |
| Geode Capital Management, LLC | 19,024 | 0.53% | $63.54K | −2,602 | 0.00% |
| Vanguard Fiduciary Trust Co | 8,311 | 0.23% | $27.76K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 1,282 | 0.04% | $4.28K | +889 | 0.00% |
| UBS Group AG | 1,112 | 0.03% | $3.71K | +1,109 | 0.00% |
| Grove Bank & Trust | 1,000 | 0.03% | $3.34K | New | 0.00% |
| Morgan Stanley | 706 | 0.02% | $2.36K | +606 | 0.00% |
| Clearstead Advisors, LLC | 650 | 0.02% | $2.17K | New | 0.00% |
| Quest 10 Wealth Builders, Inc. | 380 | 0.01% | $1.27K | New | 0.00% |
| Osaic Holdings, Inc. | 300 | 0.01% | $1.00K | – | 0.00% |
| Rockefeller Capital Management L.P. | 150 | 0.00% | $501 | – | 0.00% |
| Wells Fargo & Company/Mn | 99 | 0.00% | $331 | – | 0.00% |
| Barclays PLC | 93 | 0.00% | $311 | New | 0.00% |
| Integrated Wealth Concepts LLC | 86 | 0.00% | $287 | New | 0.00% |
| Archer Investment Corp | 70 | 0.00% | $234 | +35 | 0.00% |
| IFP Advisors, Inc | 30 | 0.00% | $100 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 0M | 3.2% | 6 / 5 | 1 / 5 | 0M | 0M |
| Q1 2026 | 17 | 0M | 2.5% | 5 / 2 | 5 / 5 | 0M | 0M |
| Q4 2025 | 18 | 0M | 3.4% | 3 / 4 | 3 / 2 | 0M | 0M |
| Q3 2025 | 17 | 0M | 3.4% | 5 / 3 | 3 / 2 | 0M | 0M |
| Q2 2025 | 14 | 0M | 1.9% | 4 / 3 | 3 / 3 | 0M | 0M |
| Q1 2025 | 13 | 0M | 1.9% | 7 / 4 | 1 / 3 | 0M | 0M |
| Q4 2024 | 9 | 0M | 0.4% | 8 / 1 | 0 / 1 | 0M | 0M |
| Q3 2024 | 2 | 0M | 0.0% | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CVKD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 33,278 | 0.93% | $111.15K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 16,859 | 0.47% | $56.31K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 12,307 | 0.34% | $60.43K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 2,449 | 0.07% | $12.02K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 2,041 | 0.06% | $10.02K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,109 | 0.03% | $5.45K | 0.00% | May 31, 2026 |
| Dimensional US Sustainability Core 1 ETF | 914 | 0.03% | $1.84K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Quang X. Pham | Chairman and CEO, Director, 10% owner | 298,589 | 8.37% | Jul 1, 2026 |
| Matthew K. Szot | Chief Financial Officer | 0 | – | Dec 31, 2025 |
| James J. Ferguson III | Chief Medical Officer | – | – | Feb 6, 2025 |
| Jeffrey Scott Cole | Chief Operating Officer | – | – | Jan 24, 2025 |
| Lee Scott Golden | Director | 1,667 | 0.05% | Dec 3, 2025 |
| Glynn Wilson | Director | 50,000 | 1.40% | Jan 24, 2025 |
| John Raymond Murphy | Director | 614,792 | 17.23% | Jan 24, 2025 |
| Steven Zelenkofske | Director | 40,000 | 1.12% | Jan 24, 2025 |
| Robert Lisicki | Director | – | – | Jan 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Quang X. Pham Chairman and CEO, Director, 10% owner | Jun 29, 2026 | Sale(10b5-1 plan) | −7,400 | $3.03 | $22.42K | 98,589 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 26, 2026 | Sale(10b5-1 plan) | −9,029 | $3.05 | $27.54K | 105,989 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 25, 2026 | Sale(10b5-1 plan) | −2,127 | $3.00 | $6.38K | 115,018 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 23, 2026 | Sale(10b5-1 plan) | −2,277 | $3.20 | $7.29K | 117,145 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 22, 2026 | Sale(10b5-1 plan) | −9,167 | $3.55 | $32.54K | 119,422 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 17, 2026 | Sale(10b5-1 plan) | −513 | $3.16 | $1.62K | 128,589 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 16, 2026 | Sale(10b5-1 plan) | −3,613 | $3.18 | $11.49K | 129,102 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 15, 2026 | Sale(10b5-1 plan) | −3,666 | $3.58 | $13.12K | 132,715 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 12, 2026 | Sale(10b5-1 plan) | −12,996 | $3.94 | $51.20K | 136,381 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 11, 2026 | Sale(10b5-1 plan) | −1,462 | $4.12 | $6.02K | 149,377 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 10, 2026 | Sale(10b5-1 plan) | −3,500 | $4.21 | $14.74K | 150,839 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 9, 2026 | Sale(10b5-1 plan) | −12,992 | $4.06 | $52.75K | 154,339 |
| Quang X. Pham Chairman, CEO and Interim CFO, Director, 10% owner | Jun 8, 2026 | Sale(10b5-1 plan) | −5,893 | $4.38 | $25.81K | 167,331 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 5, 2026 | Sale(10b5-1 plan) | −2,064 | $4.42 | $9.12K | 173,224 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 4, 2026 | Sale(10b5-1 plan) | −3,898 | $4.41 | $17.19K | 175,288 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 3, 2026 | Sale(10b5-1 plan) | −2,323 | $4.26 | $9.90K | 179,186 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Jun 2, 2026 | Sale(10b5-1 plan) | −349 | $4.46 | $1.56K | 181,509 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 29, 2026 | Sale(10b5-1 plan) | −303 | $5.01 | $1.52K | 181,858 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 28, 2026 | Sale(10b5-1 plan) | −2,989 | $4.93 | $14.74K | 182,161 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 22, 2026 | Sale(10b5-1 plan) | −1,165 | $5.69 | $6.63K | 194,924 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 12, 2026 | Sale(10b5-1 plan) | −3,298 | $5.28 | $17.41K | 185,150 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | May 11, 2026 | Sale(10b5-1 plan) | −6,476 | $5.76 | $37.30K | 188,448 |
| Matthew K. Szot Chief Financial Officer | Dec 29, 2025 | Sale(10b5-1 plan) | −9,933 | $6.97 | $69.23K | 0 |
| Matthew K. Szot Chief Financial Officer | Oct 27, 2025 | Sale(10b5-1 plan) | −1,800 | $13.99 | $25.18K | 9,933 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 27, 2025 | Sale(10b5-1 plan) | −1,315 | $13.99 | $18.40K | 196,089 |
| Matthew K. Szot Chief Financial Officer | Oct 24, 2025 | Sale(10b5-1 plan) | −1,800 | $13.99 | $25.18K | 11,733 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 24, 2025 | Sale(10b5-1 plan) | −1,129 | $14.03 | $15.84K | 197,404 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 13, 2025 | Sale(10b5-1 plan) | −1,800 | $14.15 | $25.47K | 198,533 |
| Matthew K. Szot Chief Financial Officer | Oct 13, 2025 | Sale(10b5-1 plan) | −1,800 | $14.07 | $25.33K | 13,533 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 9, 2025 | Sale(10b5-1 plan) | −1,800 | $14.02 | $25.24K | 200,333 |
| Matthew K. Szot Chief Financial Officer | Oct 9, 2025 | Sale(10b5-1 plan) | −1,693 | $13.99 | $23.69K | 15,333 |
| Matthew K. Szot Chief Financial Officer | Oct 6, 2025 | Sale(10b5-1 plan) | −107 | $13.99 | $1.50K | 17,026 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 2, 2025 | Sale(10b5-1 plan) | −500 | $14.13 | $7.07K | 202,133 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 1, 2025 | Sale(10b5-1 plan) | −881 | $14.01 | $12.34K | 202,633 |
| Matthew K. Szot Chief Financial Officer | Oct 1, 2025 | Sale(10b5-1 plan) | −1,700 | $13.99 | $23.78K | 17,133 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 29, 2025 | Sale(10b5-1 plan) | −419 | $14.01 | $5.87K | 203,514 |
| Matthew K. Szot Chief Financial Officer | Sep 29, 2025 | Sale(10b5-1 plan) | −100 | $14.00 | $1.40K | 18,833 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 25, 2025 | Sale(10b5-1 plan) | −6,790 | $14.09 | $95.67K | 203,933 |
| Matthew K. Szot Chief Financial Officer | Sep 25, 2025 | Sale(10b5-1 plan) | −10,900 | $14.05 | $153.15K | 18,933 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 24, 2025 | Sale(10b5-1 plan) | −2,581 | $13.99 | $36.11K | 210,723 |
| Matthew K. Szot Chief Financial Officer | Sep 24, 2025 | Sale(10b5-1 plan) | −1,500 | $14.00 | $21.00K | 29,833 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Aug 28, 2025 | Sale(10b5-1 plan) | −1,193 | $13.99 | $16.69K | 213,304 |
| Matthew K. Szot Chief Financial Officer | Aug 28, 2025 | Sale(10b5-1 plan) | −400 | $14.00 | $5.60K | 31,333 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Aug 27, 2025 | Sale(10b5-1 plan) | −3,836 | $13.99 | $53.67K | 214,497 |
| Matthew K. Szot Chief Financial Officer | Aug 27, 2025 | Sale(10b5-1 plan) | −1,600 | $14.00 | $22.40K | 31,733 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Apr 10, 2024 | Gift | −50,000 | – | – | 3,275,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Oct 23, 2023 | Gift | −85,000 | – | – | 3,325,000 |
| John Raymond Murphy Director | Oct 5, 2023 | Buy | +2,669 | $0.69 | $1.84K | 614,792 |
| John Raymond Murphy Director | Oct 4, 2023 | Buy | +17,331 | $0.70 | $12.13K | 612,123 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 5, 2023 | Buy | +20,000 | $0.90 | $18.00K | 3,410,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 5, 2023 | Buy | +20,000 | $0.91 | $18.20K | 3,390,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +20,000 | $0.92 | $18.40K | 3,350,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +20,000 | $0.93 | $18.60K | 3,330,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +10,000 | $0.92 | $9.20K | 3,360,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +10,000 | $0.84 | $8.40K | 3,370,000 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Sep 1, 2023 | Buy | +10,000 | $0.93 | $9.30K | 3,310,000 |
| John Raymond Murphy Director | Mar 21, 2023 | Buy | +10,000 | $1.39 | $13.90K | 594,792 |
| John Raymond Murphy Director | Mar 16, 2023 | Buy | +20,000 | $1.67 | $33.40K | 574,792 |
| Quang X. Pham CEO and Chairman, Director, 10% owner | Feb 10, 2023 | Award | +25,000 | $1.94 | $48.50K | 3,300,000 |
| Glynn Wilson Director | Jan 24, 2023 | Conversion | +50,000 | – | – | 50,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| X. Pham Quang Officer | Jun 15, 2026 | 40,000 | $148.40K | Jun 15, 2026 | Founders Shares |
| X. Pham Quang Officer | May 11, 2026 | 60,000 | $348.60K | May 11, 2026 | Founders Shares |
| K. Szot Matthew Officer | Dec 29, 2025 | 9,933 | $73.60K | Dec 29, 2025 | Founders Shares |
| X. Pham Quang Officer | Oct 27, 2025 | 1,315 | $18.40K | Oct 27, 2025 | Founders Shares |
| Szot Matthew Officer | Oct 27, 2025 | 1,800 | $25.44K | Oct 27, 2025 | Founders Shares |
| X. Pham Quang Officer | Oct 24, 2025 | 1,129 | $15.84K | Oct 24, 2025 | Founders Shares |
| Szot Matthew Officer | Oct 24, 2025 | 1,800 | $24.79K | Oct 24, 2025 | Founders Shares |
| X. Pham Quang Officer | Oct 14, 2025 | 1,800 | $25.47K | Oct 13, 2025 | Founders Shares |
| Szot Matthew Officer | Oct 14, 2025 | 1,800 | $24.52K | Oct 13, 2025 | Founders Shares |
| Szot Matthew Officer | Oct 9, 2025 | 1,693 | $23.63K | Oct 9, 2025 | Founders Shares |
| X. Pham Quang Officer | Oct 9, 2025 | 1,800 | $25.23K | Oct 9, 2025 | Founders Shares |
| Szot Matthew Officer | Oct 6, 2025 | 107 | $1.52K | Oct 6, 2025 | Founders Shares |
| X. Pham Quang Officer | Oct 2, 2025 | 500 | $7.07K | Oct 2, 2025 | Founders Shares |
| X. Pham Quang Officer | Oct 1, 2025 | 881 | $12.34K | Oct 1, 2025 | Founders Shares |
| Szot Matthew Officer | Oct 1, 2025 | 1,700 | $23.51K | Oct 1, 2025 | Founders Shares |